273 research outputs found
Wound dressing products: A translational investigation from the bench to the market
Chronic skin wounds affect more than 40 million patients globally and represent a severe growing burden for the healthcare systems, with annual costs expected to exceed $15 billions by 2022. To satisfy the huge demand for effective wound care products, different types of wound dressings have been introduced on the market during the last decades. Based on “the moist wound healing theory” postulated by Prof Winter in 1962, bandages were initially designed to recreate the optimal wound environment to favor the healing process. Then, thanks to the advancements achieved in biomaterial design and processing, biotechnology, imaging and electronic fields, great effort has been devoted to the development of formulations able to actively participate to tissue healing. Indeed, both the literature and the market report the design of medicated wound dressings, i.e., wound care products releasing anti-microbial agents, anti-inflammatory drugs, or bioactive molecules. In this scenario, this review aims at critically describing the currently available wound care products, highlighting their proved effectiveness in wound management. Moreover, an overview of the main strategies exploited to design personalized wound dressings has been reported. Lastly, concerns on regulatory affairs and practical issues limiting the clinical translation of advanced research platforms have also been discussed
In Vitro Models of Bacterial Biofilms: Innovative Tools to Improve Understanding and Treatment of Infections
Bacterial infections are a growing concern to the health care systems. Bacteria in the human body are often found embedded in a dense 3D structure, the biofilm, which makes their eradication even more challenging. Indeed, bacteria in biofilm are protected from external hazards and are more prone to develop antibiotic resistance. Moreover, biofilms are highly heterogeneous, with properties dependent on the bacteria species, the anatomic localization, and the nutrient/flow conditions. Therefore, antibiotic screening and testing would strongly benefit from reliable in vitro models of bacterial biofilms. This review article summarizes the main features of biofilms, with particular focus on parameters affecting biofilm composition and mechanical properties. Moreover, a thorough overview of the in vitro biofilm models recently developed is presented, focusing on both traditional and advanced approaches. Static, dynamic, and microcosm models are described, and their main features, advantages, and disadvantages are compared and discussed
Injectable thermosensitive gels for the localized and controlled delivery of biomolecules in tissue engineering/regenerative medicine.
Catalyst preparation for fluidized bed reactors by spray drying
Spray dried fluidized bed catalysts belong to the Geldart Group A classification and vary between 22 m to 200 m in diameter (1). Binder is either distributed throughout the particle with the active phase or surrounds the active phase as in a core-shell structure (2, 3). We slurried WO3/TiO2 micronized powder (0.2 m to 2 m) with colloidal silica (LUDOX® HS-40) to form a slurry with a mass fraction of 5 % to 20 % solids. The solution entered the top of GB-22 Yamato fluidized bed spray dryer chamber (0.12 m ID) through a two-fluid nozzle and the drying air entered the bottom counter-currently. We varied the feed slurry concentration, binder concentration, slurry and drying air flow rates, two-phase nozzle pressure drop and inlet temperature.
Most conditions only produced a very fine powder (Group C, dpm) (Fig. 1a). (Ideally, the particle size should exceed 80 m for laboratory experimental equipment). The small particles were often fully spherical but we also produced large clusters that reached 150 m (Fig. 1b). The high pressure drop through the nozzle and low slurry concentration produced the fine powder. Particles agglomerated in the fluidized bed when we increased the slurry flow rate to the chamber such that the powder had not yet dried sufficiently.
Please click Additional Files below to see the full abstract
Estimation of the effect of SLCO1B1 polymorphisms on lopinavir plasma concentration in HIV-Infected Adults
Background—The organic anion transporting polypeptides (OATP)/SLCO family represents an important class of hepatic drug uptake transporters that mediate the sodium independent transport of a diverse range of amphipathic organic compounds, including the protease inhibitors. The
SLCO1B1 521T>C (rs4149056) single nucleotide polymorphism (SNP) has been consistently associated with reduced transport activity in vivo, and we previously showed an association of this polymorphism with lopinavir plasma concentrations. The aim of this study was to develop a
population pharmacokinetic (PK) model to quantify the impact of 521T>C.
Methods—A population PK analysis was performed with 594 plasma samples from 375 patients receiving lopinavir/ritonavir. Non-linear mixed effects modelling was applied to explore the effects of SLCO1B1 521T>C and patient demographics. Simulations of the lopinavir
concentration profile were performed with different dosing regimens considering the different alleles.
Results—A one-compartment model with first-order absorption best described the data.
Population clearance was 5.67 L/h with inter-patient variability of 37%. Body weight was the only
demographic factor influencing clearance, which increased 0.5 L/h for every 10 kg increase.
Homozygosity for the C allele was associated with a 37% lower clearance, and 14% for heterozygosity, which were statistically significant.
Conclusion—These data show an association between SLCO1B1 521T>C and lopinavir clearance. The association is likely to be mediated through reduced uptake by hepatocytes leading
to higher plasma concentrations of lopinavir. Further studies are now required to confirm the association and to assess the influence of other polymorphisms in the SLCO family on lopinavir
PK
- …